ClinicalTrials.govpublic full text
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
solid tumor, non-small cell lung cancer, head and neck cancer, colorectal cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 894403
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.